Cardiovascular Drugs and Therapy


Publication Venue For

  • Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease.  36:475-481. 2022
  • The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD 2021
  • Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.  33:189-199. 2019
  • Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.  32:453-461. 2018
  • Unmet Patient Need in Statin Intolerance: the Clinical Characteristics and Management.  32:29-36. 2018
  • Barriers to Beta-Blocker Use and Up-Titration Among Patients with Heart Failure with Reduced Ejection Fraction.  31:559-564. 2017
  • Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis.  31:419-431. 2017
  • Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line: Editorial to: “Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes” by N. Hammoudi et al..  31:229-232. 2017
  • Primary Care Physician Perspectives on Barriers to Statin Treatment.  31:303-309. 2017
  • Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.  30:525-533. 2016
  • Burden of Coronary Heart Disease Rehospitalizations Following Acute Myocardial Infarction in Older Adults.  30:323-331. 2016
  • Linking the cardiomyocyte circadian clock to myocardial metabolism.  22:115-124. 2008
  • Regulation of cardiac substrate utilization by protein O-glycosylation.  22:140-140. 2008
  • Severe sinus bradycardia after initiation of bupropion therapy: A probable drug-drug interaction with metoprolol.  18:329-330. 2004
  • Reduction of infarct size by short-term pretreatment with atorvastatin.  17:25-30. 2003
  • International Standard Serial Number (issn)

  • 0920-3206
  • Electronic International Standard Serial Number (eissn)

  • 1573-7241